Enliven: Bioinformatics is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments and supports current and upcoming research in the field of bioinformatics. This journal also allows articles on genomics, and proteomics.
This journal will support the budding scientists, scholars, academicians, researchers, and students by providing Open access platform for publishing their work.
This journal will follow the peer review policies and will bode Open access in having quality research output.
This journal combines the innovative scientific ideas and ways in Bioinformatics and all other related disciplines to have an innovative output.
Enliven: Bioinformatics invites articles from authors and we assure authors that articles received will be processed with the best policies and will disseminate the articles to the right field.
Enliven: Bioinformatics aims to publish recent studies, innovations, discoveries, and developments in Bioinformatics, databases, bio grid, System biology, DNA tools, algorithms and programming, protein prediction and determination, and all other related areas.
Official Media Partners:
Biotech Pharma Summit: Biobanking 2018 will bring together the world’s leading experts in biorepositories, policy makers, and scientific actors to strengthen knowledge in biobanking as well as explore future advances in the field of biosampling for precision medicine, drug development and health research.
Go through: https://biotechpharmasummit.com/index.php/event/biobanking-2018/ for further details
On 14 & 15 June 2018, Paris will host the BioTech Pharma Summit: Genomics & Big Data 2018 conference. This year’s event brings together representatives from big pharma, academic institutions, and government research labs that will present data on advances in new technology and case studies on therapeutic targets, molecular diagnostics, and integration of complex data.
Go through: https://biotechpharmasummit.com/index.php/event/genomics-big-data-2018/ for further details
On 10 & 11 December 2018, Amsterdam (Netherlands) will host the BioTech Pharma Summit: Peptides 2018 conference. This year’s event will bring together key decision makers and innovators within this rapidly growing field. This intensive 2-Day program will examine various peptide discovery and synthesis techniques and synthesized and modified peptides.
Go through: https://biotechpharmasummit.com/index.php/event/peptides-2018/ for further details
On 17 & 18 September 2018, Basel (Switzerland) will host the BioTech Pharma Summit: Microbiome Development 2018 conference. This year’s event will bring together leaders and senior industry experts in microbiome drug discovery & development to help accelerate the precise translation of microbiome R&D from disease causation into safe, effective and commercially scalable therapeutics.
Go through: https://biotechpharmasummit.com/index.php/event/microbiome-development-2018/ for further details
Proteomics 2018 welcomes attendees, presenters, and exhibitors from all over the world to Rome-Italy. We are delighted to invite you all to attend and register for the “World Congress on Proteomics and Bioinformatics” which is going to be held during August 22-23, 2018 Rome-Italy.
Proteomics 2018 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
The conference will be organized around the Theme Extensive Study in Research Advancement in Proteomics and Bioinformatics. Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Proteomics and Bioinformatics and share the cross-cultural experiences of various advanced techniques.
Proteomics 2018 is an annual meeting of proteomics and bioinformatics as well as committees to discuss the recent research in the field of proteomics and bioinformatics in terms of collaboration, structures and organizational development.
E mail ID: email@example.com
Biotrains is delighted to invite you to Pharma Data Analytics Summit bringing together industry leaders, technical experts, data scientist, innovators, and academia in Data Analytics to share their expertise, insights and experiences on key challenges, potential solutions and best practices in the industry. The conference provides an interactive forum with thought leaders presenting latest developments, case studies, round table and panel discussion, interactive Q & A sessions to further develop and answer your queries and vibrant exhibition space with solution providers showcasing their technologies and software.
Selection of cases and controls for DNA sequencing studies using family histories of disease.
- The suggested technique was successfully applied to genome-wide association studies for type 2 diabetes, and this study analysis results reveal the practical value of the proposed techniques.
Depiction of a Novel Signal Transducer Element Intrinsic to Class IIIa/b Adenylate Cyclases and Guanylate Cyclases.
- Ths study suggesting that membrane-delimited receiver domains are transducing regulatory signals to the downstream catalytic domains in an engineered AC model system. This may forecast a previously unknown mechanism for cellular cAMP regulation.
Brassica napus transcriptome analysis - Leptosphaeria maculans pathosystem identifies receptor, signalling and structural genes underlying plant resistance.
- This dataset is providing an unprecedented spatial and temporal resolution into the genes necessary for blackleg resistance and serves as a valuable resource to those interested in host-pathogen interactions.
Pre-existing neutralizing antibody reduces B cell dysregulation and improves the Env-specific antibody response in SHIV-infected rhesus macaques.
- This study suggesting that B cell dysregulation during the early stages of infection likely contributes to suboptimal Env-specific B cell and antibody responses, and strategies that limit this dysregulation may improve the host's ability to eliminate
From electronic health records, genome-wide study of resistant hypertension has been identified.
- This study data highlighting both the difficulties and the potential utility of EHR-linked genomic data to study clinically-relevant traits such as resistant hypertension.